SBI Healthcare Opportunities Fund vs Nippon India Pharma Fund compare
SBI Healthcare Opportunities Fund - Regular Plan -Growth
Invest NowNippon India Pharma Fund-Growth Plan-Growth Option
Invest NowChart Comparison
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Fund | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹3416 Cr | ₹8689 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 31 Dec 2004 | 05 Jun 2004 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 32% | 21% |
Expense Ratio | 1.95 | 1.81 |
Manager | Pradeep Kesavan | Sailesh Raj Bhan |
ISIN Code | INF200K01446 | INF204K01968 |
Exits Load | SBI Healthcare Opportunities Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 15 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Month | 2.92% | 3.03% |
6 Month | 18.22% | 13.37% |
1 Year | 43% | 36.31% |
3 Year | 24.89% | 20.52% |
5 Year | 29.13% | 27.7% |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
6 Month | - | - |
1 Year | 35.46% | 26.5% |
3 Year | 34.45% | 30.42% |
5 Year | 27.66% | 25.06% |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
1 Year | 14.51% | 17.79% |
3 Year | 17.07% | 20.87% |
5 Year | 12.42% | 20.18% |
Scheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Standard Deviation | 14.02% | 14.36% |
Sharp | 0.78% | 0.68% |
Beta | 0.87% | 0.91% |
Alpha | 3.06% | 1.57% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts GuidanceScheme Name | SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Name | Pradeep Kesavan | Sailesh Raj Bhan |
Total AUM | ₹434274 Cr | ₹96086 Cr |
Fund Manage | 43 | 5 |
SBI Healthcare Opportunities Fund - Regular Plan -Growth | Nippon India Pharma Fund-Growth Plan-Growth Option |
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 7.82 | 4.4 |
Small Cap | 37.28 | 22.52 |
Mid Cap | 24.84 | 27.12 |
Large Cap | 30.06 | 45.96 |
Scheme Name |
SBI Healthcare Opportunities Fund - Regular Plan -Growth |
Nippon India Pharma Fund-Growth Plan-Growth Option |
---|---|---|
Others | 7.82 | 4.4 |
Pharmaceuticals & Biotechnology | 57.84 | 75.86 |
Healthcare Services | 25.46 | 17.38 |
Chemicals & Petrochemicals | 3.5 | - |
Healthcare Equipment & Supplies | 5.38 | - |
Retailing | - | 2.36 |
Top Comparisons
Franklin Build India Fund Growth Plan
3Y Returns29.42%
HSBC Infrastructure Fund - Regular Growth
3Y Returns26.66%
Franklin India Feeder - Franklin U.S. Opportunities Fund - Growth
3Y Returns7.2%
PGIM India Global Equity Opportunities Fund - Growth
3Y Returns5.54%
Aditya Birla Sun Life Arbitrage Fund - Regular Plan - Growth
3Y Returns6.19%
Axis Arbitrage Fund - Regular Plan - Growth
3Y Returns6.22%
SBI Short Term Debt Fund - Regular Plan -Growth
3Y Returns5.86%
Axis Short Duration Fund - Regular Plan - Growth Option
3Y Returns6.06%